Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2002
Business Overview: The Company operates in two primary segments: Oral, Personal and Household Care, and Pet Nutrition. Operations are reported across four geographic regions: North America, Latin America, Europe, and Asia/Africa.
Key Financial Metrics
| Metric ($ Millions) | Q2 2002 | Q2 2001 | 6M 2002 | 6M 2001 |
|---|---|---|---|---|
| Net Sales | 2,297.0 | 2,238.7 | 4,492.2 | 4,450.9 |
| Gross Profit | 1,244.0 | 1,188.2 | 2,446.8 | 2,368.6 |
| Operating Profit | 517.8 | 469.6 | 978.5 | 911.1 |
| Net Income | 327.0 | 287.2 | 616.7 | 555.1 |
| Diluted EPS | $0.55 | $0.47 | $1.04 | $0.91 |
| Operating Cash Flow (6M) | 699.1 | 621.9 | ||
| Cash & Equivalents (End Period) | 247.4 | 251.1 | ||
| Total Debt (Current + Long-Term) | 3,773.7 | 3,238.5 |
Margins (Q2 2002 vs Q2 2001):
- Gross Margin: 54.2% (up from 53.1%)
- Operating Margin: 22.5% (up from 21.0%)
- SG&A as % of Sales: 31.6% (down from 32.1%)
Material Changes vs. Prior Period
- Sales Growth: Q2 2002 sales increased 3.0% year-over-year. Excluding divestitures and foreign currency impacts, sales rose 4.0% driven by 4.0% unit volume growth. The Oral, Personal and Household Care segment grew 2.0%, while Pet Nutrition grew 8.5%.
- Profitability: Operating profit increased 10% in Q2 and 7% for the first half of 2002. Net income rose 14% in Q2 and 11% for the first half.
- Accounting Changes: The Company adopted SFAS No. 142 (Goodwill and Other Intangible Assets) effective Jan 1, 2002. Goodwill is no longer amortized. Prior period 2001 results were not restated, but adjusted figures show 2001 Net Income would have been higher by $11.0M (Q2) and $22.2M (6M) without amortization charges.
- Debt Levels: Total debt increased significantly due to new issuances. Long-term debt rose from $2,812.0M to $3,283.7M, and current notes/loans increased from $101.6M to $136.1M.
- Share Repurchases: The Company spent $631.5M on common stock repurchases in the first half of 2002, compared to $706.0M in the prior year.
Guidance, Outlook, and Risks
- Outlook: Management expects total tax payments for 2002 to exceed prior year levels. The effective tax rate for the first half was 32.0%, which reflects the current estimate for the full year.
- Unusual Items: Q2 2002 Net Income included a net one-time $2 million after-tax loss. This comprised a $13 million gain from a legal settlement offset by $15 million in charges for unrelated legal proceedings and rationalization programs.
- Foreign Exchange: The strong Euro contributed a net $6 million after-tax gain in Q2, while Latin American currencies resulted in a net $7 million charge for the first half.
- Liquidity & Covenants: The Company is in full compliance with debt covenants requiring a minimum ratio of operating cash flow to debt. Management believes the likelihood of non-compliance is remote.
- Legal Proceedings: Referenced in Part II, Item 1, with details available in the 2001 10-K. No new material legal proceedings were detailed in this filing beyond the settled matter mentioned above.
Investor Verification Checklist
- Debt Structure: Verify the sustainability of the increased debt load ($3.77B total) against operating cash flows, noting the $390.5M net proceeds from debt issuance used for buybacks.
- Accounting Adjustments: Confirm understanding of the SFAS 142 impact on comparability; 2001 EPS figures are not directly comparable without adding back goodwill amortization.
- Foreign Currency Exposure: Assess the volatility of results due to currency fluctuations, particularly the divergence between the strong Euro and weak Latin American currencies.
- Legal Contingencies: Review the 2001 10-K for details on the "unrelated legal proceedings" that contributed to the $15M charge in Q2 2002.
- Dividend Policy: Note the dividend declaration of $0.36 per share for the first half of 2002, an increase from $0.32 in the prior year.